- Home
- MFIN vs TVGN Comparison
MFIN vs TVGN Comparison
Compare MFIN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIN
- TVGN
- Stock Information
- Founded
- MFIN 1995
- TVGN 2020
- Country
- MFIN United States
- TVGN United States
- Employees
- MFIN N/A
- TVGN N/A
- Industry
- MFIN Finance: Consumer Services
- TVGN Blank Checks
- Sector
- MFIN Finance
- TVGN Finance
- Exchange
- MFIN Nasdaq
- TVGN Nasdaq
- Market Cap
- MFIN 190.0M
- TVGN 174.4M
- IPO Year
- MFIN 1996
- TVGN N/A
- Fundamental
- Price
- MFIN $9.02
- TVGN $1.35
- Analyst Decision
- MFIN
- TVGN
- Analyst Count
- MFIN 0
- TVGN 0
- Target Price
- MFIN N/A
- TVGN N/A
- AVG Volume (30 Days)
- MFIN 45.6K
- TVGN 1.7M
- Earning Date
- MFIN 02-18-2025
- TVGN 02-20-2025
- Dividend Yield
- MFIN 4.88%
- TVGN N/A
- EPS Growth
- MFIN N/A
- TVGN N/A
- EPS
- MFIN 1.69
- TVGN N/A
- Revenue
- MFIN $293,257,000.00
- TVGN N/A
- Revenue This Year
- MFIN N/A
- TVGN N/A
- Revenue Next Year
- MFIN $11.69
- TVGN N/A
- P/E Ratio
- MFIN $5.33
- TVGN N/A
- Revenue Growth
- MFIN 18.48
- TVGN N/A
- 52 Week Low
- MFIN $6.48
- TVGN $0.26
- 52 Week High
- MFIN $10.50
- TVGN $21.09
- Technical
- Relative Strength Index (RSI)
- MFIN 42.27
- TVGN 55.34
- Support Level
- MFIN $8.84
- TVGN $1.24
- Resistance Level
- MFIN $9.47
- TVGN $1.57
- Average True Range (ATR)
- MFIN 0.25
- TVGN 0.17
- MACD
- MFIN -0.03
- TVGN 0.02
- Stochastic Oscillator
- MFIN 34.15
- TVGN 58.49
About MFIN Medallion Financial Corp.
Medallion Financial Corp is a finance company that originates and services loans in various industries. Its operating segments include recreation, home improvement, commercial lending, medallion lending and Corporate and Other Investments. The company generates maximum revenue from the Recreation segment.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.